Silverfin false false 28/11/2024 29/11/2023 28/11/2024 Nicole Sutherland 10/05/2016 James Sutherland 29/11/2007 01 July 2025 The principle activity of the company during this financial year was that of a holding company. 06441308 2024-11-28 06441308 bus:Director1 2024-11-28 06441308 bus:Director2 2024-11-28 06441308 2023-11-28 06441308 core:CurrentFinancialInstruments 2024-11-28 06441308 core:CurrentFinancialInstruments 2023-11-28 06441308 core:ShareCapital 2024-11-28 06441308 core:ShareCapital 2023-11-28 06441308 core:RetainedEarningsAccumulatedLosses 2024-11-28 06441308 core:RetainedEarningsAccumulatedLosses 2023-11-28 06441308 bus:OrdinaryShareClass1 2024-11-28 06441308 bus:OrdinaryShareClass2 2024-11-28 06441308 bus:OrdinaryShareClass3 2024-11-28 06441308 bus:OrdinaryShareClass4 2024-11-28 06441308 bus:OrdinaryShareClass5 2024-11-28 06441308 bus:OtherShareClass1 2024-11-28 06441308 bus:OtherShareClass2 2024-11-28 06441308 bus:OtherShareClass3 2024-11-28 06441308 bus:PreferenceShareClass1 2024-11-28 06441308 2023-11-29 2024-11-28 06441308 bus:FilletedAccounts 2023-11-29 2024-11-28 06441308 bus:SmallEntities 2023-11-29 2024-11-28 06441308 bus:AuditExemptWithAccountantsReport 2023-11-29 2024-11-28 06441308 bus:PrivateLimitedCompanyLtd 2023-11-29 2024-11-28 06441308 bus:Director1 2023-11-29 2024-11-28 06441308 bus:Director2 2023-11-29 2024-11-28 06441308 2022-11-29 2023-11-28 06441308 bus:OrdinaryShareClass1 2023-11-29 2024-11-28 06441308 bus:OrdinaryShareClass1 2022-11-29 2023-11-28 06441308 bus:OrdinaryShareClass2 2023-11-29 2024-11-28 06441308 bus:OrdinaryShareClass2 2022-11-29 2023-11-28 06441308 bus:OrdinaryShareClass3 2023-11-29 2024-11-28 06441308 bus:OrdinaryShareClass3 2022-11-29 2023-11-28 06441308 bus:OrdinaryShareClass4 2023-11-29 2024-11-28 06441308 bus:OrdinaryShareClass4 2022-11-29 2023-11-28 06441308 bus:OrdinaryShareClass5 2023-11-29 2024-11-28 06441308 bus:OrdinaryShareClass5 2022-11-29 2023-11-28 06441308 bus:OtherShareClass1 2023-11-29 2024-11-28 06441308 bus:OtherShareClass1 2022-11-29 2023-11-28 06441308 bus:OtherShareClass2 2023-11-29 2024-11-28 06441308 bus:OtherShareClass2 2022-11-29 2023-11-28 06441308 bus:OtherShareClass3 2023-11-29 2024-11-28 06441308 bus:OtherShareClass3 2022-11-29 2023-11-28 06441308 bus:PreferenceShareClass1 2023-11-29 2024-11-28 06441308 bus:PreferenceShareClass1 2022-11-29 2023-11-28 iso4217:GBP xbrli:pure xbrli:shares

Company No: 06441308 (England and Wales)

MAYHAVEN HEALTHCARE LIMITED

Unaudited Financial Statements
For the financial year ended 28 November 2024
Pages for filing with the registrar

MAYHAVEN HEALTHCARE LIMITED

Unaudited Financial Statements

For the financial year ended 28 November 2024

Contents

MAYHAVEN HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION

As at 28 November 2024
MAYHAVEN HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 28 November 2024
Note 2024 2023
£ £
Fixed assets
Investments 3 1,134,663 1,134,663
1,134,663 1,134,663
Current assets
Debtors 4 456,203 455,543
Cash at bank and in hand 1,000 1,000
457,203 456,543
Creditors: amounts falling due within one year 5 ( 451,819) ( 449,059)
Net current assets 5,384 7,484
Total assets less current liabilities 1,140,047 1,142,147
Net assets 1,140,047 1,142,147
Capital and reserves
Called-up share capital 6 1,135,697 1,135,697
Profit and loss account 4,350 6,450
Total shareholders' funds 1,140,047 1,142,147

For the financial year ending 28 November 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Mayhaven Healthcare Limited (registered number: 06441308) were approved and authorised for issue by the Board of Directors on 01 July 2025. They were signed on its behalf by:

James Sutherland
Director
MAYHAVEN HEALTHCARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 November 2024
MAYHAVEN HEALTHCARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 November 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Mayhaven Healthcare Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor, Stratus House Emperor Way, Exeter Business Park, Exeter, Devon, England, EX1 3QS, United Kingdom. The principal place of business is 19 Seymour Park, Mannamead, Plymouth, Devon, PL35BQ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Fixed asset investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Fixed asset investments

2024 2023
£ £
Subsidiary undertakings 1,134,663 1,134,663

4. Debtors

2024 2023
£ £
Amounts owed by Group undertakings 456,203 455,543

5. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 39,999 36,999
Accruals 2,460 2,700
Other creditors 409,360 409,360
451,819 449,059

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1 H ordinary share of £ 1.00 1 1
1,102,615 A ordinary shares of £ 1.00 each 1,102,615 1,102,615
11,026 B ordinary shares of £ 1.00 each 11,026 11,026
11,026 C ordinary shares of £ 1.00 each 11,026 11,026
11,026 D ordinary shares of £ 1.00 each 11,026 11,026
1 I ordinary share of £ 1.00 1 1
1 J ordinary share of £ 1.00 1 1
1 K ordinary share of £ 1.00 1 1
1,135,697 1,135,697
409,000 6.00% Debt redeemable preference shares of £ 1.00 each 409,000 409,000
1,544,697 1,544,697

The redeemable preference shares are treated as debt and recognised within other creditors.

7. Related party transactions

Transactions with the entity's directors

2024 2023
£ £
Amounts owed to the Directors 39,999 36,999

The amounts are repayable on demand and no interest is charged on the balances.